Author:
Pauline Percier-Lehebel
Author address:
Belgium
Full conference title:
European Academy of Allergy and Clinical Immunology Congress 2019
Abstract:
Background
Aspergillus fumigatus is one of the most ubiquitous of the airborne saprophytic fungi. This fungi species can induce serious diseases like aspergillosis, allergic Aspergillus sinusitis. However, this aggressive fungi species can also activate detrimental Th2 responses in the lungs leading to the development of an allergic inflammation in such hosts. The early events inducing the allergic inflammation induced by Aspergillus fumigatus are actually not defined.
Method
Bone marrow-derived dendritic cells (BMDCs) from wild type or deficient C57Bl/6 mice were stimulated in vitro with Aspergillus fumigatus conidia and then transferred into wild type mice by intranasal administration. Fourteen days after the transfer, all mice were challenged with conidia intra-nasally and the lung inflammations were analysed three days later.
Results
This fungus species induced a strong lung Th2 response with a high recruitment of eosinophils in broncho-alveolar lavages and an increase of Th2 cytokine mRNA in lung homogenat.
The transfer of BMDCs deficient for the expression of MyD88 induced a worsening of the allergic lung inflammation, which is specific of the Aspergillus fumigatus species. Same results were observed with the transfer of TLR2 deficient BMDCs and addition of a TLR2 ligand (PamCSK4) in the culture of WT BMDCs pulsed with Aspergillus fumigatus reduced significantly the allergic lung inflammation.
However, when BMDCs were unable to produce IL-10, this induced an increase of the allergic inflammation.
Conclusion
These results indicate that the TLR2/MyD88 pathway on BMDCs is able to control the allergic response generated by Aspergillus fumigatus probably through the production of IL-10 cytokine.
Abstract Number: LBOA1708
Conference Year: 2019
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a